DOUGLAS E WILLIAMS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS E WILLIAMS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS E WILLIAMS. DOUGLAS E WILLIAMS is a EVP Research & Development in BIOGEN INC. ($IDPH) and a CSO, EVP R&D in SEATTLE GENETICS INC /WA ($SGEN) and a Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and a Director in Regulus Therapeutics Inc. ($RGLS) and a Director in Ovid Therapeutics Inc. ($OVID) and a President & CEO in Codiak BioSciences, Inc. ($CDAK).
Address: 21823 30TH DRIVE SE BOTHELL 98021 WA
Companies in which DOUGLAS E WILLIAMS is an Insider
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DOUGLAS E WILLIAMS: EVP Research & Development
Holdings: 11,817 shares
Latest Transaction: Jun 22 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Codiak BioSciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DOUGLAS E WILLIAMS: President & CEO
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IRONWOOD PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS E WILLIAMS: Director
Holdings: 91,856 shares
Current Value: $1,447,651
Latest Transaction: Jun 04 2018
$IRWD Market Capitalization: $2.32B
$IRWD Previous Close: $15.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ovid Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS E WILLIAMS: Director
Holdings: 5,000 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS E WILLIAMS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 03 2016
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DOUGLAS E WILLIAMS: CSO, EVP R&D
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 19 2004
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DOUGLAS E WILLIAMS
Sentiment: All, IDPH, CDAK, IRWD, OVID, RGLS, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | CDAK | Codiak BioSciences ... | WILLIAMS DOUGLAS E | President & CEO | Option Exercise | A | 26.60 | 175,000 | 4,655,000 | 175,000 | |
| Jun 08 2020 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 5.29 | 13,250 | 70,093 | 13,250 | |
| Nov 15 2019 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 2.43 | 7,437 | 18,072 | 7,437 | |
| Jun 10 2019 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 1.60 | 5,813 | 9,301 | 5,813 | |
| Aug 16 2018 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Buy | P | 6.49 | 5,000 | 32,442 | 5,000 | 0 to 5 K |
| Aug 16 2018 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Buy | P | 6.49 | 5,000 | 32,442 | 5,000 | 0 to 5 K |
| Jun 08 2018 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 8.12 | 5,813 | 47,202 | 5,813 |